JW Pharmaceutical

001067

Company Profile

  • Business description

    JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

  • Contact

    2477, Nambusunhwan-ro
    Seocho-gu
    KOR

    T: +82 28406777

    https://www.jw-pharma.co.kr

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    1,102

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,637.8012.900.15%
CAC 407,787.540.56-0.01%
DAX 4023,939.1899.01-0.41%
Dow JONES (US)42,073.4325.27-0.06%
FTSE 1008,722.353.66-0.04%
HKSE23,573.38315.071.35%
NASDAQ19,178.5377.600.41%
Nikkei 22538,432.98710.581.88%
NZX 50 Index12,281.3180.95-0.65%
S&P 5005,902.7314.180.24%
S&P/ASX 2008,409.8012.900.15%
SSE Composite Index3,363.4523.510.70%

Market Movers